Rubio-Terrés, C., Aguado, J. M., Almirante, B., Cobo, J., Grau, S., Salavert, M., . . . Rubio-Rodríguez, D. (2019). Extended-pulsed fidaxomicin versus vancomycin in patients 60 years and older with Clostridium difficile infection: Cost-effectiveness analysis in Spain. Eur J Clin Microbiol Infect Dis.
Chicago Style CitationRubio-Terrés, Carlos, José María Aguado, Benito Almirante, Javier Cobo, Santiago Grau, Miguel Salavert, Elena González Antona Sánchez, Cristina López Gutiérrez, i Darío Rubio-Rodríguez. "Extended-pulsed Fidaxomicin Versus Vancomycin in Patients 60 years and Older With Clostridium Difficile Infection: Cost-effectiveness Analysis in Spain." Eur J Clin Microbiol Infect Dis 2019.
Cita MLARubio-Terrés, Carlos, et al. "Extended-pulsed Fidaxomicin Versus Vancomycin in Patients 60 years and Older With Clostridium Difficile Infection: Cost-effectiveness Analysis in Spain." Eur J Clin Microbiol Infect Dis 2019.